nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—FMO3—Tamoxifen—pancreatic cancer	0.36	0.452	CbGbCtD
Almotriptan—CYP2E1—Dacarbazine—pancreatic cancer	0.0585	0.0734	CbGbCtD
Almotriptan—CYP2E1—Tamoxifen—pancreatic cancer	0.0466	0.0584	CbGbCtD
Almotriptan—CYP2C8—Tamoxifen—pancreatic cancer	0.0348	0.0437	CbGbCtD
Almotriptan—CYP1A2—Dacarbazine—pancreatic cancer	0.0339	0.0425	CbGbCtD
Almotriptan—CYP2C8—Erlotinib—pancreatic cancer	0.0296	0.0371	CbGbCtD
Almotriptan—CYP2C19—Tamoxifen—pancreatic cancer	0.0292	0.0366	CbGbCtD
Almotriptan—CYP1A2—Tamoxifen—pancreatic cancer	0.0269	0.0338	CbGbCtD
Almotriptan—CYP2C8—Fluorouracil—pancreatic cancer	0.0256	0.0322	CbGbCtD
Almotriptan—CYP1A2—Erlotinib—pancreatic cancer	0.0229	0.0287	CbGbCtD
Almotriptan—CYP2D6—Tamoxifen—pancreatic cancer	0.0222	0.0278	CbGbCtD
Almotriptan—CYP1A2—Fluorouracil—pancreatic cancer	0.0198	0.0249	CbGbCtD
Almotriptan—CYP2D6—Erlotinib—pancreatic cancer	0.0189	0.0237	CbGbCtD
Almotriptan—CYP3A4—Tamoxifen—pancreatic cancer	0.0141	0.0177	CbGbCtD
Almotriptan—CYP3A4—Erlotinib—pancreatic cancer	0.012	0.0151	CbGbCtD
Almotriptan—CYP3A4—Irinotecan—pancreatic cancer	0.0108	0.0136	CbGbCtD
Almotriptan—CYP2D6—Doxorubicin—pancreatic cancer	0.00931	0.0117	CbGbCtD
Almotriptan—CYP3A4—Docetaxel—pancreatic cancer	0.00794	0.00996	CbGbCtD
Almotriptan—CYP3A4—Sunitinib—pancreatic cancer	0.0079	0.00992	CbGbCtD
Almotriptan—CYP3A4—Doxorubicin—pancreatic cancer	0.00592	0.00743	CbGbCtD
Almotriptan—Dyspnoea—Gemcitabine—pancreatic cancer	0.000247	0.0013	CcSEcCtD
Almotriptan—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000246	0.0013	CcSEcCtD
Almotriptan—Insomnia—Fluorouracil—pancreatic cancer	0.000246	0.0013	CcSEcCtD
Almotriptan—Somnolence—Gemcitabine—pancreatic cancer	0.000246	0.0013	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000246	0.0013	CcSEcCtD
Almotriptan—Fatigue—Irinotecan—pancreatic cancer	0.000245	0.00129	CcSEcCtD
Almotriptan—Paraesthesia—Fluorouracil—pancreatic cancer	0.000245	0.00129	CcSEcCtD
Almotriptan—Pruritus—Sunitinib—pancreatic cancer	0.000244	0.00129	CcSEcCtD
Almotriptan—Breast disorder—Epirubicin—pancreatic cancer	0.000244	0.00129	CcSEcCtD
Almotriptan—Pain—Irinotecan—pancreatic cancer	0.000243	0.00128	CcSEcCtD
Almotriptan—Dyspnoea—Fluorouracil—pancreatic cancer	0.000243	0.00128	CcSEcCtD
Almotriptan—Mental disorder—Docetaxel—pancreatic cancer	0.000243	0.00128	CcSEcCtD
Almotriptan—Somnolence—Fluorouracil—pancreatic cancer	0.000242	0.00128	CcSEcCtD
Almotriptan—Erythema—Docetaxel—pancreatic cancer	0.000241	0.00127	CcSEcCtD
Almotriptan—Dyspepsia—Fluorouracil—pancreatic cancer	0.00024	0.00127	CcSEcCtD
Almotriptan—Nausea—Tamoxifen—pancreatic cancer	0.00024	0.00126	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000239	0.00126	CcSEcCtD
Almotriptan—Fatigue—Gemcitabine—pancreatic cancer	0.000239	0.00126	CcSEcCtD
Almotriptan—Gastritis—Epirubicin—pancreatic cancer	0.000239	0.00126	CcSEcCtD
Almotriptan—Muscular weakness—Epirubicin—pancreatic cancer	0.000238	0.00126	CcSEcCtD
Almotriptan—Pain—Gemcitabine—pancreatic cancer	0.000237	0.00125	CcSEcCtD
Almotriptan—Nausea—Erlotinib—pancreatic cancer	0.000237	0.00125	CcSEcCtD
Almotriptan—Diarrhoea—Sunitinib—pancreatic cancer	0.000236	0.00125	CcSEcCtD
Almotriptan—Dysgeusia—Docetaxel—pancreatic cancer	0.000236	0.00124	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000235	0.00124	CcSEcCtD
Almotriptan—Feeling abnormal—Irinotecan—pancreatic cancer	0.000234	0.00124	CcSEcCtD
Almotriptan—Back pain—Docetaxel—pancreatic cancer	0.000233	0.00123	CcSEcCtD
Almotriptan—Pain—Fluorouracil—pancreatic cancer	0.000233	0.00123	CcSEcCtD
Almotriptan—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000233	0.00123	CcSEcCtD
Almotriptan—Dizziness—Sunitinib—pancreatic cancer	0.000228	0.0012	CcSEcCtD
Almotriptan—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000228	0.0012	CcSEcCtD
Almotriptan—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000228	0.0012	CcSEcCtD
Almotriptan—Angina pectoris—Epirubicin—pancreatic cancer	0.000227	0.0012	CcSEcCtD
Almotriptan—Breast disorder—Doxorubicin—pancreatic cancer	0.000226	0.00119	CcSEcCtD
Almotriptan—Abdominal pain—Irinotecan—pancreatic cancer	0.000225	0.00119	CcSEcCtD
Almotriptan—Body temperature increased—Irinotecan—pancreatic cancer	0.000225	0.00119	CcSEcCtD
Almotriptan—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000225	0.00118	CcSEcCtD
Almotriptan—Bronchitis—Epirubicin—pancreatic cancer	0.000224	0.00118	CcSEcCtD
Almotriptan—Gastritis—Doxorubicin—pancreatic cancer	0.000221	0.00117	CcSEcCtD
Almotriptan—Muscular weakness—Doxorubicin—pancreatic cancer	0.00022	0.00116	CcSEcCtD
Almotriptan—Vomiting—Sunitinib—pancreatic cancer	0.00022	0.00116	CcSEcCtD
Almotriptan—Body temperature increased—Gemcitabine—pancreatic cancer	0.000219	0.00116	CcSEcCtD
Almotriptan—Rash—Sunitinib—pancreatic cancer	0.000218	0.00115	CcSEcCtD
Almotriptan—Dermatitis—Sunitinib—pancreatic cancer	0.000218	0.00115	CcSEcCtD
Almotriptan—Headache—Sunitinib—pancreatic cancer	0.000216	0.00114	CcSEcCtD
Almotriptan—Syncope—Docetaxel—pancreatic cancer	0.000216	0.00114	CcSEcCtD
Almotriptan—Body temperature increased—Fluorouracil—pancreatic cancer	0.000215	0.00114	CcSEcCtD
Almotriptan—Palpitations—Docetaxel—pancreatic cancer	0.000213	0.00112	CcSEcCtD
Almotriptan—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000213	0.00112	CcSEcCtD
Almotriptan—Loss of consciousness—Docetaxel—pancreatic cancer	0.000212	0.00112	CcSEcCtD
Almotriptan—Hyperglycaemia—Epirubicin—pancreatic cancer	0.00021	0.00111	CcSEcCtD
Almotriptan—Angina pectoris—Doxorubicin—pancreatic cancer	0.00021	0.00111	CcSEcCtD
Almotriptan—Hypersensitivity—Irinotecan—pancreatic cancer	0.00021	0.00111	CcSEcCtD
Almotriptan—Convulsion—Docetaxel—pancreatic cancer	0.000209	0.0011	CcSEcCtD
Almotriptan—Hypertension—Docetaxel—pancreatic cancer	0.000208	0.0011	CcSEcCtD
Almotriptan—Bronchitis—Doxorubicin—pancreatic cancer	0.000208	0.00109	CcSEcCtD
Almotriptan—Myalgia—Docetaxel—pancreatic cancer	0.000205	0.00108	CcSEcCtD
Almotriptan—Arthralgia—Docetaxel—pancreatic cancer	0.000205	0.00108	CcSEcCtD
Almotriptan—Chest pain—Docetaxel—pancreatic cancer	0.000205	0.00108	CcSEcCtD
Almotriptan—Nausea—Sunitinib—pancreatic cancer	0.000205	0.00108	CcSEcCtD
Almotriptan—Asthenia—Irinotecan—pancreatic cancer	0.000204	0.00108	CcSEcCtD
Almotriptan—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000204	0.00108	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000204	0.00107	CcSEcCtD
Almotriptan—Conjunctivitis—Epirubicin—pancreatic cancer	0.000202	0.00107	CcSEcCtD
Almotriptan—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000201	0.00106	CcSEcCtD
Almotriptan—Dry mouth—Docetaxel—pancreatic cancer	0.000201	0.00106	CcSEcCtD
Almotriptan—Asthenia—Gemcitabine—pancreatic cancer	0.000199	0.00105	CcSEcCtD
Almotriptan—Confusional state—Docetaxel—pancreatic cancer	0.000198	0.00105	CcSEcCtD
Almotriptan—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000197	0.00104	CcSEcCtD
Almotriptan—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000197	0.00104	CcSEcCtD
Almotriptan—Epistaxis—Epirubicin—pancreatic cancer	0.000196	0.00103	CcSEcCtD
Almotriptan—Pruritus—Gemcitabine—pancreatic cancer	0.000196	0.00103	CcSEcCtD
Almotriptan—Sinusitis—Epirubicin—pancreatic cancer	0.000195	0.00103	CcSEcCtD
Almotriptan—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000195	0.00103	CcSEcCtD
Almotriptan—Diarrhoea—Irinotecan—pancreatic cancer	0.000195	0.00103	CcSEcCtD
Almotriptan—Shock—Docetaxel—pancreatic cancer	0.000193	0.00102	CcSEcCtD
Almotriptan—Nervous system disorder—Docetaxel—pancreatic cancer	0.000193	0.00102	CcSEcCtD
Almotriptan—Pruritus—Fluorouracil—pancreatic cancer	0.000193	0.00102	CcSEcCtD
Almotriptan—Tachycardia—Docetaxel—pancreatic cancer	0.000192	0.00101	CcSEcCtD
Almotriptan—Skin disorder—Docetaxel—pancreatic cancer	0.000191	0.00101	CcSEcCtD
Almotriptan—Diarrhoea—Gemcitabine—pancreatic cancer	0.00019	0.001	CcSEcCtD
Almotriptan—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000189	0.000995	CcSEcCtD
Almotriptan—Dizziness—Irinotecan—pancreatic cancer	0.000188	0.000992	CcSEcCtD
Almotriptan—Rhinitis—Epirubicin—pancreatic cancer	0.000187	0.000987	CcSEcCtD
Almotriptan—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000187	0.000987	CcSEcCtD
Almotriptan—Diarrhoea—Fluorouracil—pancreatic cancer	0.000186	0.000983	CcSEcCtD
Almotriptan—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000186	0.00098	CcSEcCtD
Almotriptan—Pharyngitis—Epirubicin—pancreatic cancer	0.000185	0.000978	CcSEcCtD
Almotriptan—Epistaxis—Doxorubicin—pancreatic cancer	0.000182	0.000958	CcSEcCtD
Almotriptan—Vomiting—Irinotecan—pancreatic cancer	0.000181	0.000954	CcSEcCtD
Almotriptan—Sinusitis—Doxorubicin—pancreatic cancer	0.000181	0.000952	CcSEcCtD
Almotriptan—Dizziness—Fluorouracil—pancreatic cancer	0.00018	0.00095	CcSEcCtD
Almotriptan—Visual impairment—Epirubicin—pancreatic cancer	0.00018	0.000949	CcSEcCtD
Almotriptan—Rash—Irinotecan—pancreatic cancer	0.000179	0.000946	CcSEcCtD
Almotriptan—Dermatitis—Irinotecan—pancreatic cancer	0.000179	0.000945	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000179	0.000945	CcSEcCtD
Almotriptan—Headache—Irinotecan—pancreatic cancer	0.000178	0.00094	CcSEcCtD
Almotriptan—Insomnia—Docetaxel—pancreatic cancer	0.000178	0.000938	CcSEcCtD
Almotriptan—Paraesthesia—Docetaxel—pancreatic cancer	0.000177	0.000932	CcSEcCtD
Almotriptan—Vomiting—Gemcitabine—pancreatic cancer	0.000176	0.000929	CcSEcCtD
Almotriptan—Dyspnoea—Docetaxel—pancreatic cancer	0.000175	0.000925	CcSEcCtD
Almotriptan—Somnolence—Docetaxel—pancreatic cancer	0.000175	0.000922	CcSEcCtD
Almotriptan—Rash—Gemcitabine—pancreatic cancer	0.000175	0.000922	CcSEcCtD
Almotriptan—Dermatitis—Gemcitabine—pancreatic cancer	0.000175	0.000921	CcSEcCtD
Almotriptan—Eye disorder—Epirubicin—pancreatic cancer	0.000174	0.00092	CcSEcCtD
Almotriptan—Tinnitus—Epirubicin—pancreatic cancer	0.000174	0.000918	CcSEcCtD
Almotriptan—Headache—Gemcitabine—pancreatic cancer	0.000174	0.000916	CcSEcCtD
Almotriptan—Cardiac disorder—Epirubicin—pancreatic cancer	0.000173	0.000914	CcSEcCtD
Almotriptan—Vomiting—Fluorouracil—pancreatic cancer	0.000173	0.000914	CcSEcCtD
Almotriptan—Rhinitis—Doxorubicin—pancreatic cancer	0.000173	0.000914	CcSEcCtD
Almotriptan—Dyspepsia—Docetaxel—pancreatic cancer	0.000173	0.000913	CcSEcCtD
Almotriptan—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000172	0.000907	CcSEcCtD
Almotriptan—Rash—Fluorouracil—pancreatic cancer	0.000172	0.000906	CcSEcCtD
Almotriptan—Dermatitis—Fluorouracil—pancreatic cancer	0.000172	0.000905	CcSEcCtD
Almotriptan—Pharyngitis—Doxorubicin—pancreatic cancer	0.000171	0.000904	CcSEcCtD
Almotriptan—Headache—Fluorouracil—pancreatic cancer	0.000171	0.0009	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00017	0.000896	CcSEcCtD
Almotriptan—Fatigue—Docetaxel—pancreatic cancer	0.00017	0.000894	CcSEcCtD
Almotriptan—Nausea—Irinotecan—pancreatic cancer	0.000169	0.000891	CcSEcCtD
Almotriptan—Immune system disorder—Epirubicin—pancreatic cancer	0.000169	0.00089	CcSEcCtD
Almotriptan—Pain—Docetaxel—pancreatic cancer	0.000168	0.000887	CcSEcCtD
Almotriptan—Chills—Epirubicin—pancreatic cancer	0.000168	0.000884	CcSEcCtD
Almotriptan—Visual impairment—Doxorubicin—pancreatic cancer	0.000166	0.000878	CcSEcCtD
Almotriptan—Nausea—Gemcitabine—pancreatic cancer	0.000165	0.000868	CcSEcCtD
Almotriptan—Mental disorder—Epirubicin—pancreatic cancer	0.000164	0.000863	CcSEcCtD
Almotriptan—Erythema—Epirubicin—pancreatic cancer	0.000163	0.000857	CcSEcCtD
Almotriptan—Feeling abnormal—Docetaxel—pancreatic cancer	0.000162	0.000855	CcSEcCtD
Almotriptan—Nausea—Fluorouracil—pancreatic cancer	0.000162	0.000854	CcSEcCtD
Almotriptan—Eye disorder—Doxorubicin—pancreatic cancer	0.000161	0.000852	CcSEcCtD
Almotriptan—Tinnitus—Doxorubicin—pancreatic cancer	0.000161	0.00085	CcSEcCtD
Almotriptan—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000161	0.000848	CcSEcCtD
Almotriptan—Cardiac disorder—Doxorubicin—pancreatic cancer	0.00016	0.000846	CcSEcCtD
Almotriptan—Tension—Epirubicin—pancreatic cancer	0.000159	0.000841	CcSEcCtD
Almotriptan—Dysgeusia—Epirubicin—pancreatic cancer	0.000159	0.00084	CcSEcCtD
Almotriptan—Nervousness—Epirubicin—pancreatic cancer	0.000158	0.000833	CcSEcCtD
Almotriptan—Back pain—Epirubicin—pancreatic cancer	0.000157	0.000829	CcSEcCtD
Almotriptan—Immune system disorder—Doxorubicin—pancreatic cancer	0.000156	0.000823	CcSEcCtD
Almotriptan—Abdominal pain—Docetaxel—pancreatic cancer	0.000155	0.00082	CcSEcCtD
Almotriptan—Body temperature increased—Docetaxel—pancreatic cancer	0.000155	0.00082	CcSEcCtD
Almotriptan—Chills—Doxorubicin—pancreatic cancer	0.000155	0.000818	CcSEcCtD
Almotriptan—Vision blurred—Epirubicin—pancreatic cancer	0.000153	0.000808	CcSEcCtD
Almotriptan—Mental disorder—Doxorubicin—pancreatic cancer	0.000151	0.000798	CcSEcCtD
Almotriptan—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000151	0.000796	CcSEcCtD
Almotriptan—Erythema—Doxorubicin—pancreatic cancer	0.00015	0.000793	CcSEcCtD
Almotriptan—Agitation—Epirubicin—pancreatic cancer	0.000149	0.000788	CcSEcCtD
Almotriptan—Tension—Doxorubicin—pancreatic cancer	0.000148	0.000778	CcSEcCtD
Almotriptan—Dysgeusia—Doxorubicin—pancreatic cancer	0.000147	0.000777	CcSEcCtD
Almotriptan—Malaise—Epirubicin—pancreatic cancer	0.000147	0.000773	CcSEcCtD
Almotriptan—Nervousness—Doxorubicin—pancreatic cancer	0.000146	0.000771	CcSEcCtD
Almotriptan—Vertigo—Epirubicin—pancreatic cancer	0.000146	0.00077	CcSEcCtD
Almotriptan—Syncope—Epirubicin—pancreatic cancer	0.000146	0.000769	CcSEcCtD
Almotriptan—Back pain—Doxorubicin—pancreatic cancer	0.000145	0.000767	CcSEcCtD
Almotriptan—Hypersensitivity—Docetaxel—pancreatic cancer	0.000145	0.000764	CcSEcCtD
Almotriptan—Palpitations—Epirubicin—pancreatic cancer	0.000144	0.000758	CcSEcCtD
Almotriptan—Loss of consciousness—Epirubicin—pancreatic cancer	0.000143	0.000754	CcSEcCtD
Almotriptan—Vision blurred—Doxorubicin—pancreatic cancer	0.000142	0.000748	CcSEcCtD
Almotriptan—Asthenia—Docetaxel—pancreatic cancer	0.000141	0.000744	CcSEcCtD
Almotriptan—Convulsion—Epirubicin—pancreatic cancer	0.000141	0.000743	CcSEcCtD
Almotriptan—Hypertension—Epirubicin—pancreatic cancer	0.00014	0.00074	CcSEcCtD
Almotriptan—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00014	0.000736	CcSEcCtD
Almotriptan—Pruritus—Docetaxel—pancreatic cancer	0.000139	0.000734	CcSEcCtD
Almotriptan—Chest pain—Epirubicin—pancreatic cancer	0.000138	0.00073	CcSEcCtD
Almotriptan—Arthralgia—Epirubicin—pancreatic cancer	0.000138	0.00073	CcSEcCtD
Almotriptan—Myalgia—Epirubicin—pancreatic cancer	0.000138	0.00073	CcSEcCtD
Almotriptan—Agitation—Doxorubicin—pancreatic cancer	0.000138	0.000729	CcSEcCtD
Almotriptan—Anxiety—Epirubicin—pancreatic cancer	0.000138	0.000727	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000137	0.000725	CcSEcCtD
Almotriptan—Discomfort—Epirubicin—pancreatic cancer	0.000137	0.000721	CcSEcCtD
Almotriptan—Malaise—Doxorubicin—pancreatic cancer	0.000136	0.000715	CcSEcCtD
Almotriptan—Dry mouth—Epirubicin—pancreatic cancer	0.000135	0.000714	CcSEcCtD
Almotriptan—Vertigo—Doxorubicin—pancreatic cancer	0.000135	0.000713	CcSEcCtD
Almotriptan—Syncope—Doxorubicin—pancreatic cancer	0.000135	0.000711	CcSEcCtD
Almotriptan—Diarrhoea—Docetaxel—pancreatic cancer	0.000135	0.00071	CcSEcCtD
Almotriptan—Confusional state—Epirubicin—pancreatic cancer	0.000134	0.000706	CcSEcCtD
Almotriptan—Palpitations—Doxorubicin—pancreatic cancer	0.000133	0.000701	CcSEcCtD
Almotriptan—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000133	0.0007	CcSEcCtD
Almotriptan—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000132	0.000697	CcSEcCtD
Almotriptan—Shock—Epirubicin—pancreatic cancer	0.000131	0.000688	CcSEcCtD
Almotriptan—Convulsion—Doxorubicin—pancreatic cancer	0.00013	0.000687	CcSEcCtD
Almotriptan—Nervous system disorder—Epirubicin—pancreatic cancer	0.00013	0.000686	CcSEcCtD
Almotriptan—Dizziness—Docetaxel—pancreatic cancer	0.00013	0.000686	CcSEcCtD
Almotriptan—Hypertension—Doxorubicin—pancreatic cancer	0.00013	0.000685	CcSEcCtD
Almotriptan—Tachycardia—Epirubicin—pancreatic cancer	0.000129	0.000683	CcSEcCtD
Almotriptan—Skin disorder—Epirubicin—pancreatic cancer	0.000129	0.00068	CcSEcCtD
Almotriptan—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000128	0.000676	CcSEcCtD
Almotriptan—Chest pain—Doxorubicin—pancreatic cancer	0.000128	0.000675	CcSEcCtD
Almotriptan—Arthralgia—Doxorubicin—pancreatic cancer	0.000128	0.000675	CcSEcCtD
Almotriptan—Myalgia—Doxorubicin—pancreatic cancer	0.000128	0.000675	CcSEcCtD
Almotriptan—Anxiety—Doxorubicin—pancreatic cancer	0.000128	0.000673	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000127	0.000671	CcSEcCtD
Almotriptan—Discomfort—Doxorubicin—pancreatic cancer	0.000126	0.000667	CcSEcCtD
Almotriptan—Dry mouth—Doxorubicin—pancreatic cancer	0.000125	0.000661	CcSEcCtD
Almotriptan—Vomiting—Docetaxel—pancreatic cancer	0.000125	0.00066	CcSEcCtD
Almotriptan—Rash—Docetaxel—pancreatic cancer	0.000124	0.000654	CcSEcCtD
Almotriptan—Dermatitis—Docetaxel—pancreatic cancer	0.000124	0.000654	CcSEcCtD
Almotriptan—Confusional state—Doxorubicin—pancreatic cancer	0.000124	0.000653	CcSEcCtD
Almotriptan—Headache—Docetaxel—pancreatic cancer	0.000123	0.00065	CcSEcCtD
Almotriptan—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000123	0.000647	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000121	0.000638	CcSEcCtD
Almotriptan—Shock—Doxorubicin—pancreatic cancer	0.000121	0.000637	CcSEcCtD
Almotriptan—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00012	0.000635	CcSEcCtD
Almotriptan—Insomnia—Epirubicin—pancreatic cancer	0.00012	0.000633	CcSEcCtD
Almotriptan—Tachycardia—Doxorubicin—pancreatic cancer	0.00012	0.000632	CcSEcCtD
Almotriptan—Skin disorder—Doxorubicin—pancreatic cancer	0.000119	0.000629	CcSEcCtD
Almotriptan—Paraesthesia—Epirubicin—pancreatic cancer	0.000119	0.000628	CcSEcCtD
Almotriptan—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000119	0.000626	CcSEcCtD
Almotriptan—Dyspnoea—Epirubicin—pancreatic cancer	0.000118	0.000624	CcSEcCtD
Almotriptan—Somnolence—Epirubicin—pancreatic cancer	0.000118	0.000622	CcSEcCtD
Almotriptan—Nausea—Docetaxel—pancreatic cancer	0.000117	0.000616	CcSEcCtD
Almotriptan—Dyspepsia—Epirubicin—pancreatic cancer	0.000117	0.000616	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000115	0.000604	CcSEcCtD
Almotriptan—Fatigue—Epirubicin—pancreatic cancer	0.000114	0.000603	CcSEcCtD
Almotriptan—Pain—Epirubicin—pancreatic cancer	0.000113	0.000598	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000112	0.00059	CcSEcCtD
Almotriptan—Insomnia—Doxorubicin—pancreatic cancer	0.000111	0.000586	CcSEcCtD
Almotriptan—Paraesthesia—Doxorubicin—pancreatic cancer	0.00011	0.000581	CcSEcCtD
Almotriptan—Dyspnoea—Doxorubicin—pancreatic cancer	0.000109	0.000577	CcSEcCtD
Almotriptan—Feeling abnormal—Epirubicin—pancreatic cancer	0.000109	0.000577	CcSEcCtD
Almotriptan—Somnolence—Doxorubicin—pancreatic cancer	0.000109	0.000576	CcSEcCtD
Almotriptan—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000108	0.000572	CcSEcCtD
Almotriptan—Dyspepsia—Doxorubicin—pancreatic cancer	0.000108	0.00057	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000106	0.000559	CcSEcCtD
Almotriptan—Fatigue—Doxorubicin—pancreatic cancer	0.000106	0.000558	CcSEcCtD
Almotriptan—Pain—Doxorubicin—pancreatic cancer	0.000105	0.000554	CcSEcCtD
Almotriptan—Body temperature increased—Epirubicin—pancreatic cancer	0.000105	0.000553	CcSEcCtD
Almotriptan—Abdominal pain—Epirubicin—pancreatic cancer	0.000105	0.000553	CcSEcCtD
Almotriptan—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000101	0.000534	CcSEcCtD
Almotriptan—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.0001	0.000529	CcSEcCtD
Almotriptan—Hypersensitivity—Epirubicin—pancreatic cancer	9.77e-05	0.000516	CcSEcCtD
Almotriptan—Abdominal pain—Doxorubicin—pancreatic cancer	9.7e-05	0.000512	CcSEcCtD
Almotriptan—Body temperature increased—Doxorubicin—pancreatic cancer	9.7e-05	0.000512	CcSEcCtD
Almotriptan—Asthenia—Epirubicin—pancreatic cancer	9.52e-05	0.000502	CcSEcCtD
Almotriptan—Pruritus—Epirubicin—pancreatic cancer	9.38e-05	0.000495	CcSEcCtD
Almotriptan—Diarrhoea—Epirubicin—pancreatic cancer	9.08e-05	0.000479	CcSEcCtD
Almotriptan—Hypersensitivity—Doxorubicin—pancreatic cancer	9.04e-05	0.000477	CcSEcCtD
Almotriptan—Asthenia—Doxorubicin—pancreatic cancer	8.81e-05	0.000465	CcSEcCtD
Almotriptan—Dizziness—Epirubicin—pancreatic cancer	8.77e-05	0.000463	CcSEcCtD
Almotriptan—Pruritus—Doxorubicin—pancreatic cancer	8.68e-05	0.000458	CcSEcCtD
Almotriptan—Vomiting—Epirubicin—pancreatic cancer	8.43e-05	0.000445	CcSEcCtD
Almotriptan—Diarrhoea—Doxorubicin—pancreatic cancer	8.4e-05	0.000443	CcSEcCtD
Almotriptan—Rash—Epirubicin—pancreatic cancer	8.36e-05	0.000441	CcSEcCtD
Almotriptan—Dermatitis—Epirubicin—pancreatic cancer	8.36e-05	0.000441	CcSEcCtD
Almotriptan—Headache—Epirubicin—pancreatic cancer	8.31e-05	0.000438	CcSEcCtD
Almotriptan—Dizziness—Doxorubicin—pancreatic cancer	8.12e-05	0.000428	CcSEcCtD
Almotriptan—Nausea—Epirubicin—pancreatic cancer	7.88e-05	0.000416	CcSEcCtD
Almotriptan—Vomiting—Doxorubicin—pancreatic cancer	7.8e-05	0.000412	CcSEcCtD
Almotriptan—Rash—Doxorubicin—pancreatic cancer	7.74e-05	0.000408	CcSEcCtD
Almotriptan—Dermatitis—Doxorubicin—pancreatic cancer	7.73e-05	0.000408	CcSEcCtD
Almotriptan—Headache—Doxorubicin—pancreatic cancer	7.69e-05	0.000406	CcSEcCtD
Almotriptan—Nausea—Doxorubicin—pancreatic cancer	7.29e-05	0.000385	CcSEcCtD
Almotriptan—HTR1B—Signaling Pathways—NOTCH3—pancreatic cancer	9.28e-06	0.000686	CbGpPWpGaD
Almotriptan—MAOA—Neuronal System—HRAS—pancreatic cancer	9.26e-06	0.000685	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GCG—pancreatic cancer	9.09e-06	0.000672	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CNR1—pancreatic cancer	8.97e-06	0.000663	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ARG2—pancreatic cancer	8.81e-06	0.000651	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CNR1—pancreatic cancer	8.79e-06	0.000649	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CG—pancreatic cancer	8.71e-06	0.000644	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—GCG—pancreatic cancer	8.67e-06	0.00064	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PIK3CB—pancreatic cancer	8.66e-06	0.00064	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—TYMP—pancreatic cancer	8.63e-06	0.000638	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PTGS2—pancreatic cancer	8.58e-06	0.000634	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—STK11—pancreatic cancer	8.55e-06	0.000632	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CG—pancreatic cancer	8.53e-06	0.00063	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—GCG—pancreatic cancer	8.49e-06	0.000627	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PIK3CD—pancreatic cancer	8.43e-06	0.000623	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AGTR1—pancreatic cancer	8.27e-06	0.000611	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PIK3CD—pancreatic cancer	8.25e-06	0.00061	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—STK11—pancreatic cancer	8.15e-06	0.000602	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ARG2—pancreatic cancer	8.11e-06	0.000599	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AGTR1—pancreatic cancer	8.09e-06	0.000598	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GLP1R—pancreatic cancer	8.05e-06	0.000595	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—STK11—pancreatic cancer	7.98e-06	0.00059	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PRSS1—pancreatic cancer	7.92e-06	0.000585	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—DPYD—pancreatic cancer	7.92e-06	0.000585	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—TYMP—pancreatic cancer	7.7e-06	0.000569	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CD—pancreatic cancer	7.66e-06	0.000566	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—SLC2A2—pancreatic cancer	7.51e-06	0.000555	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CD—pancreatic cancer	7.5e-06	0.000554	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PTEN—pancreatic cancer	7.48e-06	0.000553	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—TYMS—pancreatic cancer	7.35e-06	0.000544	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PIK3CB—pancreatic cancer	7.35e-06	0.000543	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PIK3CB—pancreatic cancer	7.19e-06	0.000532	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SMAD4—pancreatic cancer	7.14e-06	0.000527	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	7.12e-06	0.000526	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TYMP—pancreatic cancer	7.09e-06	0.000524	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CXCL8—pancreatic cancer	7.06e-06	0.000522	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SMAD4—pancreatic cancer	6.99e-06	0.000516	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HES1—pancreatic cancer	6.97e-06	0.000515	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GLP1R—pancreatic cancer	6.96e-06	0.000514	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CXCL8—pancreatic cancer	6.91e-06	0.000511	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ARG2—pancreatic cancer	6.87e-06	0.000508	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—DPYD—pancreatic cancer	6.84e-06	0.000506	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HES1—pancreatic cancer	6.82e-06	0.000504	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CB—pancreatic cancer	6.67e-06	0.000493	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CB—pancreatic cancer	6.53e-06	0.000483	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	6.5e-06	0.00048	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.43e-06	0.000475	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CXCL8—pancreatic cancer	6.41e-06	0.000474	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.36e-06	0.00047	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CXCL8—pancreatic cancer	6.28e-06	0.000464	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GLP1R—pancreatic cancer	6.21e-06	0.000459	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.2e-06	0.000458	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PRSS1—pancreatic cancer	6.11e-06	0.000452	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—DPYD—pancreatic cancer	6.11e-06	0.000451	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TERT—pancreatic cancer	6.11e-06	0.000451	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TYMP—pancreatic cancer	6e-06	0.000444	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—APOE—pancreatic cancer	5.98e-06	0.000442	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TERT—pancreatic cancer	5.98e-06	0.000442	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HIF1A—pancreatic cancer	5.84e-06	0.000431	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TSC2—pancreatic cancer	5.82e-06	0.00043	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CD44—pancreatic cancer	5.82e-06	0.00043	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	5.8e-06	0.000428	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.74e-06	0.000424	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HIF1A—pancreatic cancer	5.72e-06	0.000423	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GLP1R—pancreatic cancer	5.71e-06	0.000422	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TSC2—pancreatic cancer	5.7e-06	0.000421	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—APOE—pancreatic cancer	5.7e-06	0.000421	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.65e-06	0.000418	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—DPYD—pancreatic cancer	5.62e-06	0.000415	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KDR—pancreatic cancer	5.58e-06	0.000413	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—APOE—pancreatic cancer	5.58e-06	0.000412	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GCG—pancreatic cancer	5.58e-06	0.000412	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.54e-06	0.000409	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KDR—pancreatic cancer	5.47e-06	0.000404	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CG—pancreatic cancer	5.4e-06	0.000399	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	5.33e-06	0.000394	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NFKBIA—pancreatic cancer	5.31e-06	0.000393	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ARG2—pancreatic cancer	5.3e-06	0.000392	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PIK3CA—pancreatic cancer	5.28e-06	0.00039	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOTCH1—pancreatic cancer	5.26e-06	0.000389	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—STK11—pancreatic cancer	5.25e-06	0.000388	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PPARG—pancreatic cancer	5.21e-06	0.000385	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NFKBIA—pancreatic cancer	5.2e-06	0.000384	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOTCH1—pancreatic cancer	5.15e-06	0.000381	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CG—pancreatic cancer	5.14e-06	0.00038	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—NRAS—pancreatic cancer	5.14e-06	0.00038	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EGF—pancreatic cancer	5.08e-06	0.000376	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.04e-06	0.000373	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CG—pancreatic cancer	5.04e-06	0.000372	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—NRAS—pancreatic cancer	5.04e-06	0.000372	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CD44—pancreatic cancer	5.03e-06	0.000372	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EGF—pancreatic cancer	4.98e-06	0.000368	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.95e-06	0.000366	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.93e-06	0.000364	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.88e-06	0.000361	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GLP1R—pancreatic cancer	4.84e-06	0.000358	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GCG—pancreatic cancer	4.82e-06	0.000356	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—DPYD—pancreatic cancer	4.76e-06	0.000352	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CD—pancreatic cancer	4.75e-06	0.000351	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—EGFR—pancreatic cancer	4.69e-06	0.000346	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TYMP—pancreatic cancer	4.63e-06	0.000342	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—EGFR—pancreatic cancer	4.59e-06	0.000339	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—STK11—pancreatic cancer	4.53e-06	0.000335	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CD—pancreatic cancer	4.52e-06	0.000334	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	4.52e-06	0.000334	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—TYMS—pancreatic cancer	4.51e-06	0.000333	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CD44—pancreatic cancer	4.49e-06	0.000332	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.48e-06	0.000331	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.47e-06	0.00033	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CD—pancreatic cancer	4.43e-06	0.000327	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—KRAS—pancreatic cancer	4.43e-06	0.000327	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.4e-06	0.000325	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.39e-06	0.000324	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.36e-06	0.000322	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—KRAS—pancreatic cancer	4.34e-06	0.00032	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.31e-06	0.000319	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—AKT1—pancreatic cancer	4.31e-06	0.000319	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GCG—pancreatic cancer	4.3e-06	0.000318	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.26e-06	0.000315	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CB—pancreatic cancer	4.14e-06	0.000306	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CD44—pancreatic cancer	4.13e-06	0.000305	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTGS2—pancreatic cancer	4.1e-06	0.000303	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CA—pancreatic cancer	4.07e-06	0.000301	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—STK11—pancreatic cancer	4.05e-06	0.000299	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CA—pancreatic cancer	3.98e-06	0.000294	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GCG—pancreatic cancer	3.96e-06	0.000293	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CB—pancreatic cancer	3.94e-06	0.000291	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.93e-06	0.00029	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—TYMS—pancreatic cancer	3.9e-06	0.000288	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CB—pancreatic cancer	3.86e-06	0.000285	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.8e-06	0.000281	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CXCL8—pancreatic cancer	3.79e-06	0.00028	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HRAS—pancreatic cancer	3.76e-06	0.000278	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.73e-06	0.000276	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—STK11—pancreatic cancer	3.72e-06	0.000275	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CXCL8—pancreatic cancer	3.71e-06	0.000274	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HRAS—pancreatic cancer	3.68e-06	0.000272	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.67e-06	0.000271	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—APOE—pancreatic cancer	3.67e-06	0.000271	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—AKT1—pancreatic cancer	3.66e-06	0.00027	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CASP3—pancreatic cancer	3.63e-06	0.000268	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—AKT1—pancreatic cancer	3.58e-06	0.000265	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTEN—pancreatic cancer	3.57e-06	0.000264	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CASP3—pancreatic cancer	3.55e-06	0.000262	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCND1—pancreatic cancer	3.53e-06	0.000261	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CD44—pancreatic cancer	3.5e-06	0.000259	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CTNNB1—pancreatic cancer	3.49e-06	0.000258	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	3.49e-06	0.000258	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—TYMS—pancreatic cancer	3.48e-06	0.000257	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCND1—pancreatic cancer	3.46e-06	0.000255	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MMP9—pancreatic cancer	3.43e-06	0.000253	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.43e-06	0.000253	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CTNNB1—pancreatic cancer	3.42e-06	0.000253	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PTEN—pancreatic cancer	3.41e-06	0.000252	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.39e-06	0.000251	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MMP9—pancreatic cancer	3.35e-06	0.000248	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GCG—pancreatic cancer	3.35e-06	0.000248	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PTEN—pancreatic cancer	3.34e-06	0.000246	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—AKT1—pancreatic cancer	3.32e-06	0.000246	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	3.31e-06	0.000245	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—AKT1—pancreatic cancer	3.25e-06	0.00024	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TYMS—pancreatic cancer	3.2e-06	0.000237	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PPARG—pancreatic cancer	3.2e-06	0.000236	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—APOE—pancreatic cancer	3.17e-06	0.000234	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SRC—pancreatic cancer	3.16e-06	0.000233	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—STK11—pancreatic cancer	3.15e-06	0.000233	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SRC—pancreatic cancer	3.09e-06	0.000229	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—pancreatic cancer	3.08e-06	0.000227	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—STAT3—pancreatic cancer	3.05e-06	0.000225	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NRAS—pancreatic cancer	3.04e-06	0.000225	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—pancreatic cancer	3.01e-06	0.000223	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3e-06	0.000222	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—STAT3—pancreatic cancer	2.98e-06	0.00022	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NRAS—pancreatic cancer	2.98e-06	0.00022	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.96e-06	0.000219	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	2.91e-06	0.000215	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	2.86e-06	0.000212	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—APOE—pancreatic cancer	2.83e-06	0.000209	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MYC—pancreatic cancer	2.83e-06	0.000209	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TGFB1—pancreatic cancer	2.82e-06	0.000209	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MYC—pancreatic cancer	2.77e-06	0.000205	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EGFR—pancreatic cancer	2.77e-06	0.000205	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TGFB1—pancreatic cancer	2.76e-06	0.000204	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PPARG—pancreatic cancer	2.76e-06	0.000204	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TYMS—pancreatic cancer	2.71e-06	0.0002	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EGFR—pancreatic cancer	2.71e-06	0.0002	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CD44—pancreatic cancer	2.7e-06	0.0002	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.68e-06	0.000198	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KRAS—pancreatic cancer	2.62e-06	0.000193	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—APOE—pancreatic cancer	2.6e-06	0.000192	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GCG—pancreatic cancer	2.59e-06	0.000191	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KRAS—pancreatic cancer	2.56e-06	0.000189	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	2.56e-06	0.000189	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	2.54e-06	0.000188	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CA—pancreatic cancer	2.52e-06	0.000186	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	2.52e-06	0.000186	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTGS2—pancreatic cancer	2.51e-06	0.000186	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPARG—pancreatic cancer	2.47e-06	0.000182	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—STK11—pancreatic cancer	2.43e-06	0.00018	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CA—pancreatic cancer	2.4e-06	0.000178	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CA—pancreatic cancer	2.35e-06	0.000174	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	2.35e-06	0.000174	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—pancreatic cancer	2.32e-06	0.000172	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—pancreatic cancer	2.28e-06	0.000168	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.27e-06	0.000168	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	2.25e-06	0.000166	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HRAS—pancreatic cancer	2.22e-06	0.000164	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOE—pancreatic cancer	2.21e-06	0.000163	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	2.19e-06	0.000162	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTEN—pancreatic cancer	2.19e-06	0.000162	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HRAS—pancreatic cancer	2.18e-06	0.000161	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTGS2—pancreatic cancer	2.17e-06	0.000161	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.09e-06	0.000155	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.09e-06	0.000154	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.07e-06	0.000153	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKT1—pancreatic cancer	2.06e-06	0.000152	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.99e-06	0.000147	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKT1—pancreatic cancer	1.96e-06	0.000145	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	1.96e-06	0.000145	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTGS2—pancreatic cancer	1.94e-06	0.000143	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKT1—pancreatic cancer	1.92e-06	0.000142	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.92e-06	0.000142	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTEN—pancreatic cancer	1.9e-06	0.00014	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.8e-06	0.000133	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.78e-06	0.000132	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.75e-06	0.000129	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOE—pancreatic cancer	1.7e-06	0.000126	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.69e-06	0.000125	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.56e-06	0.000115	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	1.55e-06	0.000114	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.54e-06	0.000114	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.53e-06	0.000113	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.51e-06	0.000112	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.48e-06	0.00011	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.35e-06	9.98e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.34e-06	9.88e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.32e-06	9.74e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKT1—pancreatic cancer	1.26e-06	9.34e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.19e-06	8.82e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.18e-06	8.7e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.17e-06	8.62e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.1e-06	8.11e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.09e-06	8.07e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.02e-06	7.52e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKT1—pancreatic cancer	9.75e-07	7.21e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	9.3e-07	6.87e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKT1—pancreatic cancer	8.97e-07	6.63e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKT1—pancreatic cancer	7.6e-07	5.61e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	7.18e-07	5.3e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKT1—pancreatic cancer	5.86e-07	4.33e-05	CbGpPWpGaD
